Pace Analytical Life Sciences®, LLC, a subsidiary of Pace Analytical® Services, LLC, a full-service CDMO, has acquired Velesco Pharmaceutical Services, Inc., a CDMO, specializing in liquid, semi-solid, and oral solid dose product development.   “Pace scientists and professionals provide expertise and support to clients throughout their drug development timeline,” said Eric Roman, CEO of Pace Analytical. “Adding Velesco to our portfolio is representative of our commitment to s...